Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.

Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M, LiGHT Trial Study Group. · 2019

Read Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. by Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M, LiGHT Trial Study Group. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6495367.txt.

Description

Gazzard and co-authors report the LiGHT trial, a head-to-head test of selective laser trabeculoplasty against daily eye drops as the first treatment for open angle glaucoma and ocular hypertension. Seven hundred eighteen treatment-naïve patients at six UK hospitals were randomized, 356 to laser and 362 to drops, and followed for three years with quality of life as the main outcome.

Quality-of-life scores ended identical, but the paths differed. In the laser-first group, 74.2 percent of patients needed no drops at all to hold target pressure at 36 months. Their eyes were on target at more visits. None required glaucoma surgery, against 11 in the drops group. Laser first carried a 97 percent probability of being more cost-effective, and the authors say it should be offered first-line.

Catalog record

CREATORGazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M, LiGHT Trial Study Group.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6495367

Browse the full library · About the Tower of Babel